BioCentury
ARTICLE | Company News

Rosetta Genomics, Admera Health sales and marketing update

May 4, 2015 7:00 AM UTC

Rosetta launched Admera’s laboratory developed test (LDT), OncoGxOne to detects alterations in 64 genes implicated in cancer and chemotherapy. Rosetta has rights to the test under a 2014 deal. ...